Xie Bing, Liu Yaping, Li Xiaotong, Yang Pei, He Wei
School of Pharmacy, China Pharmaceutical University, Nanjing 2111198, China.
School of Science, China Pharmaceutical University, Nanjing 2111198, China.
Acta Pharm Sin B. 2024 Nov;14(11):4683-4716. doi: 10.1016/j.apsb.2024.08.027. Epub 2024 Sep 2.
About 40% of approved drugs and nearly 90% of drug candidates are poorly water-soluble drugs. Low solubility reduces the drugability. Effectively improving the solubility and bioavailability of poorly water-soluble drugs is a critical issue that needs to be urgently addressed in drug development and application. This review briefly introduces the conventional solubilization techniques such as solubilizers, hydrotropes, cosolvents, prodrugs, salt modification, micronization, cyclodextrin inclusion, solid dispersions, and details the crystallization strategies, ionic liquids, and polymer-based, lipid-based, and inorganic-based carriers in improving solubility and bioavailability. Some of the most commonly used approved carrier materials for solubilization techniques are presented. Several approved poorly water-soluble drugs using solubilization techniques are summarized. Furthermore, this review summarizes the solubilization mechanism of each solubilization technique, reviews the latest research advances and challenges, and evaluates the potential for clinical translation. This review could guide the selection of a solubilization approach, dosage form, and administration route for poorly water-soluble drugs. Moreover, we discuss several promising solubilization techniques attracting increasing attention worldwide.
约40%的已批准药物和近90%的候选药物为低水溶性药物。低溶解度降低了药物可开发性。有效提高低水溶性药物的溶解度和生物利用度是药物研发与应用中亟待解决的关键问题。本综述简要介绍了增溶剂、助溶剂、共溶剂、前药、盐修饰、微粉化、环糊精包合、固体分散体等传统增溶技术,并详细阐述了结晶策略、离子液体以及基于聚合物、脂质和无机的载体在提高溶解度和生物利用度方面的应用。介绍了一些增溶技术中最常用的已批准载体材料。总结了几种采用增溶技术的已批准低水溶性药物。此外,本综述总结了每种增溶技术的增溶机制,回顾了最新研究进展与挑战,并评估了临床转化潜力。本综述可为低水溶性药物增溶方法、剂型和给药途径的选择提供指导。此外,我们还讨论了几种在全球范围内受到越来越多关注的有前景的增溶技术。